4 - Invizyne Technologies Inc (0002010788) (Issuer)

Monrovia, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, announced it was awarded a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel (SAF). The project is a cost share grant from the U.S. Department of Defense's BioMADE initiative, in partnership with the University of Georgia. It is one of 17 BioMADE projects announced on October 30, 2024, to drive the scale-up and commercialization of American biomanufactured products. "The nex

Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the closing of its initial public offering of 1,875,000 shares of its common stock at a public offering price of $8.00 per share. The shares began trading on NASDAQ under the ticker symbol "IZTC" on November 13, 2024. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were approximately $15,000,000. The Company has granted a 45-day option to the underwriter to purchase up to 2

4 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

4 - Invizyne Technologies Inc (0002010788) (Issuer)

4 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)

3 - Invizyne Technologies Inc (0002010788) (Issuer)